Core Viewpoint - The company has achieved significant breakthroughs in its international expansion, with overseas sales revenue increasing by 53.04% year-on-year, accounting for 55.61% of total revenue [1] Group 1: International Market Performance - The company's products are now available in nearly 100 countries and regions across Europe, North America, South America, Asia, Africa, and Oceania [1] - The participation in international CPHI exhibitions and the advancement of product registration and qualified supplier listings have contributed to the gradual increase in market penetration in high-end markets such as Europe and the United States [1] Group 2: Global Operations - The company's global operational capabilities are continuously improving, reflecting its commitment to expanding its presence in international markets [1]
海森药业：国际化战略全面推进，境外销售实现跨越式增长